Original Source(s)
Related Content
FDA Approves First Therapy for Allergic Fungal Rhinosinusitis
Patients with allergic fungal rhinosinusitis now have a targeted biologic option.
February 25, 2026
-
2 min
Prisms, Vision Therapy Reduce AACE
Retrospective cohort shows 79% of patients improved without surgery, with measurable gains in divergence and reduced esodeviation
March 5, 2026
-
4 min